EMPROVE® qualification

Request Information


Supporting Risk Assessment, Increasing Pharma Raw Materials Know-How

Emprove – Selecting the right tool for the job
With the ever increasing regulatory challenges drug manufacturers are facing, collecting information for your risk assessment can be costly and time-consuming. For its 10th anniversary, we have expanded our EMPROVE® regulatory documentation to offer you even more support for your risk assessment. What's new?:
  • Supply chain information supports transparency
  • New Product Quality Reports inform about the consistency of our products.
  • Information on elemental impurity levels of EMPROVE® products step by step/product by product
With a portfolio of 400 EMPROVE® raw materials, Merck Millipore helps you obtain standardized qualification documentation you need to smoothen your qualification and approval processes.
Benefits:
  • Facilitating risk assessment
  • Speed approval preparation for faster time to market
  • Time and money savings
  • Create formulations with full regulatory compliance
Merck Millipore's EMPROVE® portfolio includes the following product lines:
Our EMPROVE® dossiers comprise detailed, usage-specific documentation that includes information on manufacturing, test methods, purity and stability data, helping you to successfully navigate regulatory challenges.
 
 
Webinar: New Guideline on Elemental Impurities and its Implication - Register now!

Webinar:
New guideline on elemental impurities and its implications

Watch Now
Sign up for our pharmail newsletter – more news, more service - Click here

pharmail Newsletter
More news, more service

Sign up now!

Events

Jun 23
23/06/15
6. Merck Millipore Pharma Forum (German)
Merck KGaA Atrium
Darmstadt, Germany
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing Europe 20150623